Diversification Rating
8 /10
Expense Ratio Rating
10 /10
Expense Rating
10 /10
Market Score
8 /10
Category Score
8 /10
Market Size
8 /10
We found 8,043 US Stocks Large Value funds. Here they are ordered by FI Score.
ProShares UltraShort Nasdaq Biotechnology
Expenses: 0.95% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternative fund. See why »
Eaton Vance Emerging and Frontier Countries Equity Fund Class I
Expenses: 1.41% (Better than 0% of similar funds)
This is a bad choice for a Emerging Markets International Stocks fund. See why »
Goldman Sachs Target Date 2025 Portfolio A Shares
Expenses: 0.52% (Better than 0% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
MFS Lifetime 2035 Fund Class C
Expenses: 0.99% (Better than 0% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
MFS Lifetime 2025 Fund Class C
Expenses: 0.99% (Better than 0% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
Catalyst Insider Income Fund Class I
Expenses: 0.75% (Better than 1% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
Federated U.S. Government Securities Fund 1-3 Years Service Shares
Expenses: 0.86% (Better than 0% of similar funds)
This is a bad choice for a Government Bond Bond fund. See why »
Delaware Healthcare Fund Class A
Expenses: 1.28% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
Goldman Sachs Target Date 2035 Portfolio A Shares
Expenses: 0.52% (Better than 0% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2024 Adam Fortuna
Site Map